 | Up a level |
2018
Amarasinghe, H., Wojdacz, T., Rose-Zerilli, M., Beattie, A., Forster, J., Kadalayil, L., Blakemore, S., Parker, H., Larrayoz, M., Clifford, R., Davis, Z., Else, M., Cohen, D., Steele, A., Rosenquist, R., Collins, A., Pettitt, A., Hillmen, P., Plass, C., Catovsky, D., Schuh, A., Oscier, D., Oakes, C. and Strefford, J. (2018). Patients with a Memory-like DNA Methylation Signature exhibit long-term survival after first-line immuno-chemotherapy: Data from the UK CLL4, ARCTIC and ADMIRE trials. Br. J. Haematol., 181. S. 29 - 30. HOBOKEN: WILEY. ISSN 1365-2141
2015
Bahlo, J., Kutsch, N., Bergmann, M., Byrd, J., Doehner, H., Eichhorst, B., Else, M., Geisler, C., Grever, M., Lepretre, S., Neuberg, D., Oscier, D., Robak, T., Rosenquist, R., Shanafelt, T., Stilgenbauer, S. and Hallek, M. (2015). THE INTERNATIONAL PROGNOSTIC INDEX FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI)-AN INTERNATIONAL META-ANALYSIS. Haematologica, 100. S. 313 - 315. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078